CAS 1450595-86-4

DS-1971a

CAS : 1450595-86-4

Formule : C₂₀H₂₁ClFN₅O₃S

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 465.9288

Ref: IN-DA01V74P

5-Chloro-2-Fluoro-4-(((1S,2R)-2-(1-Methyl-1H-Pyrazol-5-Yl)Cyclohexyl)Oxy)-N-(Pyrimidin-4-Yl)Benzenesulfonamide

CAS : 1450595-86-4

5-Chloro-2-Fluoro-4-(((1S,2R)-2-(1-Methyl-1H-Pyrazol-5-Yl)Cyclohexyl)Oxy)-N-(Pyrimidin-4-Yl)Benzenesulfonamide

Degré de pureté : 98%

Masse moléculaire : 465.93g/mol

Ref: 54-PC108522

DS-1971a

CAS : 1450595-86-4

DS-1971a

Degré de pureté : ≥98%

Masse moléculaire : 465.93g/mol

Ref: 54-BUP07638

DS-1971a

CAS : 1450595-86-4

DS-1971a is a highly potent and selective NaV1.7 inhibitor. DS-1971a exhibits a favorable toxicological profile and analgesic effects.

Formule : C₂₀H₂₁ClFN₅O₃S

Degré de pureté : 99.66%

Couleur et forme : Solid

Masse moléculaire : 465.93

Ref: TM-T9685

DS-1971a

CAS : 1450595-86-4

DS-1971a is a novel drug that has been shown to have neuropathic pain-relieving properties. The compound was initially synthesized as a potential analgesic, but it had not been tested in vivo until recently. It has been shown to inhibit the development of neuropathic pain by inhibiting voltage-gated sodium channels and potassium channels, which have been implicated in neuropathic pain. DS-1971a is also an inhibitor of monoamine oxidase (MAO) and acetylcholinesterase (AChE). Preclinical studies have shown that DS-1971a has a good safety profile with no toxicological effects at doses up to 500 mg/kg.

Formule : C₂₀H₂₁ClFN₅O₃S

Degré de pureté : Min. 95%

Masse moléculaire : 465.10377

Ref: 3D-BD178041